NCT04662970 Optimization of Cardiac Resynchronization Therapy by Non-Invasive Imaging of Cardiac Electrophysiology
| NCT ID | NCT04662970 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Medical University Innsbruck |
| Condition | Heart Failure |
| Study Type | INTERVENTIONAL |
| Enrollment | 25 participants |
| Start Date | 2020-01-01 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 25 participants in total. It began in 2020-01-01 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The principal aim is to analyze total left and right ventricular activation time in different CRT device programming algorithms (SyncAV) measured by non-invasive electrophysiology
Eligibility Criteria
Inclusion Criteria: * patients after successful implantation of a CRT-D or CRT-P device in whom a cardiac magnetic resonance examination is possible and the device is equipped with the SyncAV® programming software * left bundle branch block before CRT implantation * PQ interval ≤ 250 ms before implantation Exclusion Criteria: * high-grade AV block * any contraindication concerning a safe CMR performance including claustrophobia * terminal heart failure (NYHA IV) or cardiac decompensation * life expectancy \< 1 year * women with child-bearing potential, pregnancy * drug abusus
Contact & Investigator
Wolfgang Dichtl, MD PhD
PRINCIPAL INVESTIGATOR
Medical University Innsbruck
Frequently Asked Questions
Who can join the NCT04662970 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Heart Failure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04662970 currently recruiting?
Yes, NCT04662970 is actively recruiting participants. Contact the research team at dichtl@me.com for enrollment information.
Where is the NCT04662970 trial being conducted?
This trial is being conducted at Innsbruck, Austria.
Who is sponsoring the NCT04662970 clinical trial?
NCT04662970 is sponsored by Medical University Innsbruck. The principal investigator is Wolfgang Dichtl, MD PhD at Medical University Innsbruck. The trial plans to enroll 25 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.